Treatment of ACEI-related angioedema with icatibant: a case series

Internal and Emergency Medicine

Volumn 10, Issue 3, 2015, Pages 345-350

  Bova, Maria ^a   Guilarte, Mar ^b,c   Sala Cunill, Anna ^b,c   Borrelli, Paolo ^d   Rizzelli, Grazia Maria Luisa ^e   Zanichelli, Andrea ^f  

^a Unit of Radiology   (Italy)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d U Parini Regional Hospital   (Italy)

^e UNIVERSITY HOSPITAL OF PISA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

ACE inhibitors; Angioedema; Icatibant

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT;

AGED; ANALOGS AND DERIVATIVES; ANGIOEDEMA; CHEMICALLY INDUCED; FEMALE; HOSPITAL EMERGENCY SERVICE; HUMAN; MALE; MIDDLE AGED; SUBCUTANEOUS DRUG ADMINISTRATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONISTS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED;

EID: 84939958854     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-015-1205-9     Document Type: Article

References (23)

1. Byrd JB, Adam A, Brown NJ (2006) Angiotensin-converting enzyme inhibitor-associated angioedema. Immunol Allergy Clin North Am 26:725–737
2. Bas M, Greve J, Stelter K, Bier H, Stark T et al (2010) Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 56:278–282
3. Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P (2010) Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. Clin Exp Allergy 40:50–61
4. Cicardi M Aberer W, Banerji A, Bas M, Bernstein JA, et al (2014) Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy, (Epub ahead of print)
5. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A (2004) Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 164:910–913
6. Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE (2008) Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 51:1624–1630
7. Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A et al (2012) Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 110:383–391
8. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr (2008) Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 100:327–332
9. Beltrami L, Zanichelli A, Zingale L, Vacchini R, Carugo S, Cicardi M (2011) Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens 29:2273–2277
10. Manders K, van Deuren M, Hoedemaekers C, Simon A (2012) Bradykinin-receptor antagonist icatibant: possible treatment for ACE inhibitor-related angio-oedema. Neth J Med 70:386–387
11. Nielsen EW, Gramstad S (2006) Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiol Scand 50:120–122
12. Baram M, Kommuri A, Sellers SA, Cohn JR (2013) ACE inhibitor-induced angioedema. J Allergy Clin Immunol Pract 1:442–445
13. Bouillet L, Ponard D, Drouet C, Massot C (2004) Non-histaminic angiodema management: diagnostic and therapeutic interest of tranexamic acid. Rev Med Interne 25:924–926
14. Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M (2009) C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 15:69–78
15. Zanichelli A, Bova M, Coerezza A, Petraroli A, Triggiani M, Cicardi M (2012) Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study. Allergy 67:1074–1077
16. Illing EJ, Kelly S, Hobson JC, Charters S (2012) Icatibant and ACE inhibitor angioedema. BMJ Case Rep. doi: 10.1136/bcr-2012-006646
17. Fast S, Henningsen E, Bygum A (2011) Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor. UgeskrLaeger 173:2574–2575
18. Gallitelli M, Alzetta M (2012) Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors. Am J Emerg Med 30:1664.e1–1664.e2
19. Javaud N, Fain O, Bernot B, Adnet F, Lapostolle F (2011) Bradykinin-mediated angioedema secondary to angiotensin converting enzyme: initiate treatment from the prehospital phase. Ann Fr Anesth Reanim 30:848–850
20. Volans A, Ferguson R (2013) Using a bradykinin blocker in ACE inhibitor-associated angioedema in the emergency department. BMJ Case Rep. doi: 10.1136/bcr-2012-008295
21. Zanichelli A, Badini M, Nataloni I, Montano N, Cicardi M (2011) Treatment of acquired angioedema with icatibant: a case report. Intern Emerg Med 6:279–280
22. Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA (2009) Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension 54:516–523
23. Cicardi M, Bellis P, Bertazzoni G, Cancian M, Chiesa M, Cremonesi P, Marino P, Montano N, Morselli C, Ottaviani F, Perricone R, Triggiani M, Zanichelli A (2014) Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts. Intern Emerg Med 9:85–92